...

Edwards Lifesciences Corporation (EW) Intrinsic Value

DCF-based fair value calculation with Bear, Base, and Bull scenarios

Popular:

Edwards Lifesciences Corporation (EW)

View Full Profile →

Intrinsic Value (DCF)

Current$83.84
→
Intrinsic$21.01
-75%
$15.55$21.01$31.36
Current price reflects execution expectations above 25% growth — not unreasonable for quality businesses.
Range: Bear $16 → Bull $31. Current price implies expectations above the base case, closer to bull expectations.
Current price reflects assumptions at the upper end of our valuation range (bull case: $31).
Discount ↓Growth →21%23%25%27%
8%$25$27$28$30
10%$19$20$21$22
12%$15$16$17$18
14%$13$14$14$15

Bull Case

  • Bull case ($31) with 30% growth, 9% discount rate

Bear Case

  • Bear case ($16) implies 81% downside at 20% growth, 12% discount
  • Trading 75% above base case — execution must exceed assumptions to justify
  • Price exceeds bull case ($31) — requires exceptional execution
Loading charts...

5-Year Free Cash Flow Projection

Year 1$362.38M
Year 2$452.97M
Year 3$566.21M
Year 4$707.76M
Year 5$884.70M
Terminal$13.02B

📐 Model Inputs

Growth Rate25.0%5Y CAGR (cascade: 5Y→3Y→TTM)
Discount Rate10.0%WACC estimate
Terminal Growth3.0%Perpetuity rate
Base Free Cash Flow$289.90MTTM actual
Bear g×0.8, r+2%
Base Historical CAGR
Bull g×1.2, r−1.5%
ℹ️

DCF estimates based on historical growth rates extrapolated forward. See FAQ below for full methodology.

Related Analysis

Full Stock ProfileCompare EW vs AAPLStock Screener

Frequently Asked Questions

Is EW stock undervalued or overvalued?
🔴 OVERVALUED

EW trades at $83.84 vs. our DCF-derived intrinsic value of $18.07, implying -79% downside. Using a 10.0% WACC and 25.0% FCF growth assumption, the current price requires growth rates above our estimates to be justified. Even our bull case ($25.25) suggests limited upside.

What is EW's intrinsic value?

Using a 5-year DCF model: Base FCF of $290M, projected at 25.0% 5Y CAGR (best of revenue, EPS, or FCF growth), discounted at 10.0% WACC, with 3.0% terminal growth. Terminal value calculated via Gordon Growth Model: TV = FCF₅ × (1+g) / (WACC−g). After deducting $-2.35B net debt and dividing by 0.60B shares: Bear $13.20 | Base $18.07 | Bull $25.25. Current price $83.84 implies -79% to base case.

How is EW's fair value calculated?

DCF Methodology:

① Project FCF years 1-5 using 25.0% growth derived from 5-year historical CAGR (best of revenue, EPS, or FCF growth, with 8% floor and 25% cap).

② Calculate terminal value at year 5 using perpetuity growth model with g=3.0%.

③ Discount all cash flows to PV using WACC=10.0%.

④ Sum PV of explicit period + PV of terminal value = Enterprise Value ($8.49B).

⑤ Subtract net debt, divide by shares outstanding.

Sensitivity analysis available above—adjust WACC ±2% or growth ±3% to stress-test the valuation. Implied EV/FCF multiple: 29.3x.